Neuberger Berman has marked down the valuation of fintech unicorn Pine Labs by 38% to $3.1 Bn from $5 Bn
Epharmacy giant PharmEasy’s valuation was trimmed by 21% to $4.4 Bn from $5.6 Bn
This week alone, Ola and Swiggy have seen a haircut in their valuation from their respective investors
Valuation markdown is the new flavour of the season at the Indian startup ecosystem. When layoffs, and funding crunch have been haunting the startups, valuation markdown by their respective investors has now added to their woes.
Latest is, Neuberger Berman, a New York-based investment firm, has marked down the valuations of two of its major Indian portfolio companies: PharmEasy and Pine Labs.